Placeholder Banner

Complete Genomics Sequences 14 Human Genomes

September 10, 2009
Complete Genomics Inc. announced that 14 human genomes now have been sequenced, analyzed and delivered to customers since March 2009. The company’s human genome sequencing technology helps to further research for cancer, metabolic and neurological diseases. Customers include academic research institutions and biopharmaceutical companies that are conducting disease studies to investigate conditions as diverse as cancer (breast, lung, colorectal and melanoma), HIV and schizophrenia.

Complete Genomics Inc. will be presenting at the 8th Annual BIO Investor Forum in San Francisco on October 28-29.